C4 Therapeutics
CCCC
$6.74
Share price
4.82%
Change (1 day)
114.65%
Change (1 year)
Categories
C4 Therapeutics (CCCC) - P/B ratio
P/B ratio as of May 2024 : 1.79
According to C4 Therapeutics's latest financial reports the company has a price-to-book ratio of 1.79.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
C4 Therapeutics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.13 | 13.29% |
| 2022-12-31 | 0.9987 | -75.15% |
| 2021-12-31 | 4.02 | -20.84% |
| 2020-12-31 | 5.08 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | 59.82% | 🇺🇸 USA |